Anant A. Agrawal

2.2k total citations
14 papers, 589 citations indexed

About

Anant A. Agrawal is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Anant A. Agrawal has authored 14 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 2 papers in Genetics and 2 papers in Cancer Research. Recurrent topics in Anant A. Agrawal's work include RNA modifications and cancer (11 papers), RNA Research and Splicing (11 papers) and RNA and protein synthesis mechanisms (8 papers). Anant A. Agrawal is often cited by papers focused on RNA modifications and cancer (11 papers), RNA Research and Splicing (11 papers) and RNA and protein synthesis mechanisms (8 papers). Anant A. Agrawal collaborates with scholars based in United States, Italy and Germany. Anant A. Agrawal's co-authors include Silvia Buonamici, Peter G. Smith, Clara L. Kielkopf, Jermaine L. Jenkins, Nicholas Larsen, Andrew S. Cook, Peter Fekkes, Lihua Yu, Constantin Cretu and Vladimir Peña and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

In The Last Decade

Anant A. Agrawal

14 papers receiving 573 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anant A. Agrawal United States 11 527 78 74 37 29 14 589
Lorenza A. D’Alessandro Germany 9 239 0.5× 159 2.0× 101 1.4× 63 1.7× 31 1.1× 15 412
Daphné Dupéré-Richer United States 9 347 0.7× 51 0.7× 77 1.0× 14 0.4× 42 1.4× 18 409
Guilherme Augusto dos Santos Brazil 11 317 0.6× 98 1.3× 117 1.6× 15 0.4× 33 1.1× 25 406
Stela Álvarez-Fernández Spain 8 216 0.4× 76 1.0× 118 1.6× 49 1.3× 38 1.3× 11 363
Mai Itoh Japan 11 243 0.5× 53 0.7× 58 0.8× 39 1.1× 49 1.7× 31 361
Rebecca A. Bilardi Australia 8 219 0.4× 40 0.5× 71 1.0× 22 0.6× 27 0.9× 11 292
Byung Seon Chung South Korea 10 255 0.5× 96 1.2× 55 0.7× 29 0.8× 28 1.0× 12 351
Dong-Jun Lin China 11 277 0.5× 76 1.0× 89 1.2× 27 0.7× 26 0.9× 11 420
Yu Hyun Jeon South Korea 13 389 0.7× 104 1.3× 22 0.3× 35 0.9× 24 0.8× 17 478
Sang Wu Lee South Korea 11 329 0.6× 97 1.2× 19 0.3× 19 0.5× 23 0.8× 14 405

Countries citing papers authored by Anant A. Agrawal

Since Specialization
Citations

This map shows the geographic impact of Anant A. Agrawal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anant A. Agrawal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anant A. Agrawal more than expected).

Fields of papers citing papers by Anant A. Agrawal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anant A. Agrawal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anant A. Agrawal. The network helps show where Anant A. Agrawal may publish in the future.

Co-authorship network of co-authors of Anant A. Agrawal

This figure shows the co-authorship network connecting the top 25 collaborators of Anant A. Agrawal. A scholar is included among the top collaborators of Anant A. Agrawal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anant A. Agrawal. Anant A. Agrawal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Neil, Christopher R., Cassandra Schaening-Burgos, Maria S. Alexis, et al.. (2025). Poison exons: tuning RNA splicing for targeted gene regulation. Trends in Pharmacological Sciences. 46(3). 264–278. 2 indexed citations
2.
Neil, Christopher R., Michael Seiler, Dominic J. Reynolds, et al.. (2022). Reprogramming RNA processing: an emerging therapeutic landscape. Trends in Pharmacological Sciences. 43(5). 437–454. 14 indexed citations
3.
Cretu, Constantin, Patricia Gee, Anant A. Agrawal, et al.. (2021). Structural basis of intron selection by U2 snRNP in the presence of covalent inhibitors. Nature Communications. 12(1). 4491–4491. 39 indexed citations
4.
Yao, Shihua, Tuong-Vi Nguyen, Alan Rolfe, et al.. (2021). Abstract 2334: Discovery of selective inhibitors of carbamoyl phosphate synthetase I (CPS1) to modulate cancer relevant metabolic pathways. Cancer Research. 81(13_Supplement). 2334–2334. 1 indexed citations
5.
Yao, Shihua, Tuong-Vi Nguyen, Alan Rolfe, et al.. (2020). Small Molecule Inhibition of CPS1 Activity through an Allosteric Pocket. Cell chemical biology. 27(3). 259–268.e5. 27 indexed citations
6.
Finci, Lorenzo I., Xiaofeng Zhang, Xiuliang Huang, et al.. (2018). The cryo-EM structure of the SF3b spliceosome complex bound to a splicing modulator reveals a pre-mRNA substrate competitive mechanism of action. Genes & Development. 32(3-4). 309–320. 91 indexed citations
7.
Cretu, Constantin, Anant A. Agrawal, Andrew S. Cook, et al.. (2018). Structural Basis of Splicing Modulation by Antitumor Macrolide Compounds. Molecular Cell. 70(2). 265–273.e8. 125 indexed citations
8.
Agrawal, Anant A., Lihua Yu, Peter G. Smith, & Silvia Buonamici. (2017). Targeting splicing abnormalities in cancer. Current Opinion in Genetics & Development. 48. 67–74. 61 indexed citations
9.
Agrawal, Anant A., Michael Seiler, Lindsey T. Brinton, et al.. (2017). Novel SF3B1 in-frame deletions result in aberrant RNA splicing in CLL patients. Blood Advances. 1(15). 995–1000. 8 indexed citations
10.
Agrawal, Anant A., et al.. (2017). Cancer-Associated Mutations Mapped on High-Resolution Structures of the U2AF2 RNA Recognition Motifs. Biochemistry. 56(36). 4757–4761. 22 indexed citations
11.
Agrawal, Anant A., Enea Salsi, Rakesh Chatrikhi, et al.. (2016). An extended U2AF65–RNA-binding domain recognizes the 3′ splice site signal. Nature Communications. 7(1). 10950–10950. 53 indexed citations
12.
Mupo, Annalisa, Magdalene J. Seiler, Vijitha Sathiaseelan, et al.. (2016). Hemopoietic-specific Sf3b1-K700E knock-in mice display the splicing defect seen in human MDS but develop anemia without ring sideroblasts. Leukemia. 31(3). 720–727. 91 indexed citations
13.
Agrawal, Anant A., et al.. (2014). Structure-guided U2AF 65 variant improves recognition and splicing of a defective pre-mRNA. Proceedings of the National Academy of Sciences. 111(49). 17420–17425. 15 indexed citations
14.
Jenkins, Jermaine L., Anant A. Agrawal, Ankit Gupta, Michael R. Green, & Clara L. Kielkopf. (2013). U2AF65 adapts to diverse pre-mRNA splice sites through conformational selection of specific and promiscuous RNA recognition motifs. Nucleic Acids Research. 41(6). 3859–3873. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026